首页> 外文期刊>Cellular Physiology and Biochemistry >Tunicamycin inhibits diabetes
【24h】

Tunicamycin inhibits diabetes

机译:衣霉素抑制糖尿病

获取原文
获取原文并翻译 | 示例
           

摘要

Autoimmune diseases are characterized by a breakdown of immunologic tolerance, and this breakdown can lead to life-threatening or lifelong disorders. Moreover; drugs that are used to treat these diseases are few in number and are associated with many serious adverse effects. Methods: We used the rat insulin promoter-glycoprotein mouse model to analyze the role of tunicamycin in the process of autoimmune diabetes; the P14 mouse model to analyze the effect of tunicamycin on CD8 ~+ T cells; chop knockout mice to analyze the role of tunicamycin on an endoplasmic reticulum stress model; and fluorescence-activated cell sorting, quantitative real-time polymerase chain reaction, and histologic methods. Results: We found that a single dose of tunicamycin reduced the activation and pancreatic infiltration of CD8 ~+ T cells. This activity delayed the incidence of virus-induced diabetes and improved survival rates. Conclusion: Tunicamycin may offer therapeutic opportunities for T cell-mediated autoimmune diseases such as diabetes.
机译:自身免疫性疾病的特征是免疫耐受性下降,这种破坏可能导致威胁生命或终生疾病。此外;用于治疗这些疾病的药物数量很少,并且与许多严重的不良反应有关。方法:我们使用大鼠胰岛素启动子-糖蛋白小鼠模型分析衣霉素在自身免疫性糖尿病过程中的作用;用P14小鼠模型分析衣霉素对CD8〜+ T细胞的作用;敲除小鼠以分析衣霉素在内质网应激模型中的作用;荧光激活细胞分选,实时定量聚合酶链反应和组织学方法。结果:我们发现单剂量的衣霉素减少了CD8〜+ T细胞的活化和胰腺浸润。这种活动延迟了病毒诱发的糖尿病的发生并提高了生存率。结论:衣霉素可能为糖尿病等T细胞介导的自身免疫性疾病提供治疗机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号